Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

2731 - 2740 of 58327 results found

A Randomized Trial of Nafamostat for Covid-19

Date
Tuesday, February 06, 2024 - 4:00 AM
Description
A Randomized Trial of Nafamostat for Covid-19Nafamostat mesylate is a potent in vitro antiviral that inhibits the host transmembrane protease serine 2 enzyme used by SARS-CoV-2 for cell entry. Morpeth et al report the results of an open-label

Coping during socio-political uncertainty

Date
Tuesday, February 06, 2024 - 4:00 AM
Description
INTRODUCTION: Well-being of young adults is known to be compromised in times of significant changes, such as economic and political turmoil. This study focuses on university students in Lebanon during one of the most prominent social unrests of its

Methods for SARS-CoV-2 hospital disinfection, in vitro observations

Date
Tuesday, February 06, 2024 - 4:00 AM
Description
CONCLUSION: The virucidal activity on replication-competent SARS-CoV-2 by conventional chemical methods, including chlorhexidine at concentrations as low as 0.5%, was not matched by UVC irradiation, and to an even lesser extent by ozonated water